Sign in

CIK 0001139685 · <br>Emerging growth company

20/20 Biolabs, Inc.

Sign in to watch
Ticker
AIDX
Exchange
Nasdaq
Industry
Services-Testing Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522272107
Phone
2404536339
Business address
9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD, 20850
Former names
20/20 GeneSystems, Inc., 20/20 GENE SYSTEMS INC
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 8-K Event Shareholder vote results
  5. 8-K Event Delisting notice
  6. 8-K Event Regulation FD disclosure
  7. DEFA14A Proxy Proxy Materials
  8. 8-K Event Shareholder vote results
  9. 424B3 Offering Prospectus
  10. 424B3 Offering Prospectus
  11. 8-K Event Results of operations
  12. 10-Q Report Quarterly Report
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Material agreement · Delisting notice
  15. 8-K Event Regulation FD disclosure
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  20. 424B3 Offering Prospectus

Page 1 of 9 · 167 filings